Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amlodipine/Atorvastatin 10mg/80mg Under Fed Conditions
NCT02292069Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2011
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine and atorvastatin in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area under curve (AUC) for Amlodipine. Started Sep 2011; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02292069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02292069.